NORSK HELSEKLINIKK AS
Operating
1) drive klinisk utprøving av behandlingsmetoder og legemidler i egen
regi og i samarbeid med farmasøytisk industri
2) drive forebyggende helsevirkosmhet innen vektreduksjon, kosthold,
hjertekarsykdom, røykeavvenning og lungesykdommer
3) drive undervisning av helsearbeidere i Hedmark og generell helse
opplysning i regi av Hedmark HelseForsknings Forening (HHFF)
4) evt. selge helsetjenester til bedrifter, sykehus, farmasøytisk
industri, andre, samt hva hermed står i forbindelse, herunder å
delta i andre selskpaer med lignende virksomhet.
Legesenter som skal
1, drive klinisk utprøving av behandlingsmodeller/legemidler
2, drive forebyggende helsevirksomhet
3, drive undervisning av helsearbeidere
4, salg av helsetjenester
samt hva hermed står i forbindelse / delta i andre selskaper.
Organization
- CEO
- LS
Leidulv Solnør1960
- Chairman of the board
- LS
Leidulv Solnør1960
- Years since formation
- 24 years
- since Oct 7, 2002
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Annual total result 2025
- -237,501
- NOK
- Total equity 2025
- -1,208
- NOK
Last update: May 13, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
LS 1960 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
LS 1960 | Chairman | 100 % directly |
CS 1965 | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
LS 1960 | Managing Director/CEO, Chairman | 100 % directly |
Last update: May 19, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
LS 1960 | Ordinary shares | 100 | 100 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 0 | 217,400 | 58,024 | 29,012 |
Annual Total Result | -237,501 | 173,064 | 38,859 | -5,333 |
Total assets | 82,260 | 363,144 | 165,642 | 127,511 |
Total liabilities | 83,468 | 126,852 | 102,413 | 103,142 |
Total equity | -1,208 | 236,292 | 63,229 | 24,369 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 0 | 217,400 | 58,024 | 29,012 |
Total operating costs | 237,501 | 44,341 | 19,196 | 34,321 |
Operating result | -237,501 | 173,059 | 38,828 | -5,309 |
Financial income/costs | 0 | 5 | 32 | -24 |
Profit before tax | -237,501 | 173,064 | 38,859 | -5,333 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -237,501 | 173,064 | 38,859 | -5,333 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 82,260 | 363,144 | 165,642 | 127,511 |
Total assets | 82,260 | 363,144 | 165,642 | 127,511 |
Short term debt | 83,468 | 126,852 | 102,413 | 103,142 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 83,468 | 126,852 | 102,413 | 103,142 |
Contributed capital | 102,970 | 102,970 | 102,970 | 102,970 |
Retained earnings | -104,178 | 133,322 | -39,741 | -78,601 |
Total equity | -1,208 | 236,292 | 63,229 | 24,369 |
Total equity and liabilities | 82,260 | 363,144 | 165,642 | 127,511 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises